Article

(2023) RETRACTION: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response (Retraction of Vol 39, Pg 353, 2022). Pharmaceutical research. pp. 615-616. ISSN 0724-8741

(2023) Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. Pharmaceutical research. pp. 615-616. ISSN 1573-904X (Electronic) 0724-8741 (Linking)

(2023) Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/s11095-022-03169-2). Pharmaceutical research. pp. 615-616. ISSN 07248741 (ISSN)

(2022) Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. Pharmaceutical research. pp. 353-367. ISSN 0724-8741

(2022) Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. Pharmaceutical research. ISSN 1573-904X (Electronic) 0724-8741 (Linking)

(2022) Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. Pharmaceutical research. pp. 1851-1866. ISSN 0724-8741

(2022) Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models. Life Sciences. p. 12. ISSN 0024-3205